CARLOMAGNO, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 5.512
AS - Asia 248
NA - Nord America 30
SA - Sud America 27
AF - Africa 2
Totale 5.819
Nazione #
IT - Italia 5.506
SG - Singapore 102
CN - Cina 77
VN - Vietnam 58
US - Stati Uniti d'America 27
BR - Brasile 16
AR - Argentina 6
HK - Hong Kong 5
MX - Messico 3
RU - Federazione Russa 3
BD - Bangladesh 2
EC - Ecuador 2
ID - Indonesia 2
IQ - Iraq 2
NL - Olanda 2
CL - Cile 1
DJ - Gibuti 1
GF - Guiana Francese 1
PE - Perù 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 5.819
Città #
Genova 3.121
Genoa 1.487
Vado Ligure 448
Rapallo 431
Singapore 39
Beijing 24
Ho Chi Minh City 24
Hanoi 18
Ashburn 15
Bordighera 14
Hong Kong 5
Mexico City 3
Quảng Ngãi 3
Da Nang 2
Los Angeles 2
Rondonópolis 2
Santa Clara 2
Venice 2
Amsterdam 1
Ananindeua 1
Arequipa 1
Baghdad 1
Blumenau 1
Bom Jardim 1
Boston 1
Brasília 1
Brooklyn 1
Bắc Ninh 1
Caldas Novas 1
Cayenne 1
Coronel Brandsen 1
Dallas 1
Del Viso 1
Denver 1
Duque de Caxias 1
Elista 1
Esmeraldas 1
Estación Colina 1
Guayaquil 1
Ha Long 1
Haiphong 1
Hải Dương 1
Irajuba 1
Itanhaém 1
Ituzaingó 1
Jessore 1
Luján de Cuyo 1
Lyubertsy 1
Malvinas Argentinas 1
Medan 1
Nanyang 1
New York 1
Nha Trang 1
Orlando 1
Osasco 1
Patos de Minas 1
Poltava 1
Port Elizabeth 1
Portoviejo 1
Quận Bình Thạnh 1
Quận Ninh Kiều 1
Salta 1
Shenzhen 1
Surakarta 1
São Vicente 1
Taquarana 1
Thái Bình 1
Tianjin 1
Vacaria 1
Vĩnh Tường 1
Vũng Tàu 1
Totale 5.695
Nome #
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 216
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 186
Features of Memory-Like and PD-1+ Human NK Cell Subsets 182
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 179
Bridging innate NK cell Functions with Adaptive Immunity. 178
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 177
NK/DC crosstalk in anti-viral response. 176
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 174
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 167
NK cells and their receptors during viral infections. 164
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 163
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 162
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 155
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 150
Human NK cell response to pathogens 149
Natural killer lymphocytes: "null cells" no more. 142
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2 139
TLR/NCR/KIR: Which One to Use and When? 133
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 131
Natural Killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT. 131
Natural killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT 127
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 125
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 125
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells 120
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 119
NK Cell-Based Immunotherapy for Hematological Malignancies 117
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 111
NK Cell-Based Immunotherapy in Colorectal Cancer 110
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 109
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 109
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 108
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 107
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 107
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 104
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 103
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 101
The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells 88
Anti-CD94-induced expansion of highly functional adaptive NKG2C+NKG2A−CD57+selfKIR+ NK cells from CMV-seropositive healthy donors 86
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. 83
The tryptophan catabolite L-Kynurenine affects human NK cell function 81
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma 79
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts 75
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer 71
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 65
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles 63
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 58
NK/DC crosstalk in anti-viral response 54
CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors 51
Natural killer cell impairment in ovarian clear cell carcinoma 44
Totale 5.954
Categoria #
all - tutte 19.982
article - articoli 17.069
book - libri 0
conference - conferenze 2.506
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 407
Totale 39.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 0 82 30 26 53 60 27 38
2021/2022580 15 44 61 45 19 31 41 135 28 62 31 68
2022/2023521 48 48 10 51 66 93 1 44 101 4 47 8
2023/2024325 19 41 8 45 33 26 17 29 24 27 12 44
2024/20251.052 24 67 41 76 149 112 106 159 21 46 119 132
2025/2026811 225 60 136 122 238 30 0 0 0 0 0 0
Totale 5.954